Sverica's Women's Health USA enters 2nd round of process

The Boston-based PE firm acquired a majority interest in WHUSA in August 2017, and in 2019 completed the spin-out of In Vitro Sciences into an independent platform investment.

DealsHealthcareFeaturedTop Stories